Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Safety and Effectiveness of NovoMix® 30 (Biphasic Insulin Aspart) for the Treatment of Diabetes Mellitus

NCT00659282 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00659282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00659282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Safety and Effectiveness of NovoMix® 30 (Biphasic Insulin Aspart) for the Treatment of Diabetes Mellitus
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
September 11, 2006
Completion date
November 15, 2008
Enrollment
57,610 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2